Doctors Note Logo

Published on: 9/24/2026

How should I taper off prednisone safely?

Prednisone should be tapered gradually under a doctor's guidance, never stopped abruptly, because long-term use suppresses your adrenal glands' natural cortisol production. Typical plans reduce the dose in small steps every few days to a few weeks, with slower tapers for higher doses, longer treatment courses, or when withdrawal symptoms like fatigue, body aches, nausea, joint pain, dizziness, or low mood appear. Your taper speed also depends on the condition being treated, since flares can occur if the dose drops too quickly, and several other factors matter as well, so review the complete details below before changing anything.

If you are unsure whether what you feel is steroid withdrawal, a returning flare, or something unrelated, guessing can delay care you may need. A free, instant, online symptom check takes only a few minutes, helps you organize what you are experiencing, and points you toward the right next step and the right questions for your prescriber.

Last reviewed for medical accuracy: 09/24/2026

answer background

Explanation

How to Taper Off Prednisone Safely

Prednisone is a powerful corticosteroid used to control inflammation and suppress the immune system in conditions like asthma, rheumatoid arthritis, lupus and more. While it can be lifesaving, stopping prednisone suddenly after weeks or months of use can lead to serious withdrawal symptoms and adrenal insufficiency. This guide will help you understand why a gradual taper is crucial, outline general tapering strategies, and answer common questions—like “can I drink alcohol while taking prednisone 20 mg?”—so you can come off prednisone safely under medical supervision.


Why You Need to Taper Prednisone

  • Adrenal suppression
    Long-term prednisone tricks your body into thinking it makes enough cortisol, so your adrenal glands slow or stop production. If you stop prednisone abruptly, you may not have enough cortisol to handle daily stress or illness.

  • Risk of withdrawal
    Symptoms of steroid withdrawal include:

    • Extreme fatigue or weakness
    • Joint and muscle pain
    • Low blood pressure (dizziness when standing)
    • Nausea, vomiting, loss of appetite
    • Mood changes (low mood, irritability)
  • Preventing adrenal crisis
    In rare cases, sudden prednisone discontinuation can trigger an adrenal crisis—a life-threatening drop in blood pressure and blood sugar. A gradual taper lets your adrenal glands “wake up” and start producing cortisol again.


Factors That Affect Your Taper Schedule

Each taper should be personalized by your prescribing doctor, based on:

  1. Initial dose
    Higher doses (e.g., > 20 mg daily) often require a slower taper.

  2. Duration of therapy
    The longer you’ve been on prednisone, the slower the taper must be.

  3. Underlying condition
    Active inflammation or autoimmune disease may flare if you taper too quickly.

  4. Individual response
    Everyone reacts differently. Some people need extra time at certain dose levels before stepping down further.


General Tapering Guidelines

Below is a framework that many clinicians follow. Always consult your healthcare provider for a plan tailored to you.

  1. High-dose phase (> 20 mg daily)

    • Reduce by 5–10 mg every 1–2 weeks until you reach 20 mg.
    • Monitor closely for return of original symptoms.
  2. Mid-dose phase (10–20 mg daily)

    • Reduce by 2.5–5 mg every 2–4 weeks.
    • If you experience new symptoms, hold at the current dose longer.
  3. Low-dose phase (< 10 mg daily)

    • Reduce by 1 mg every 2–4 weeks or slower.
    • Some people need to stay at 5 mg for several weeks before going lower.
  4. Very low-dose phase (< 5 mg daily)

    • Reduce by 0.5–1 mg every 2–4 weeks.
    • Your doctor may switch you to an alternate-day dosing schedule before complete discontinuation.

What to Watch For During Taper

  • Return of original symptoms
    Joint pain, rashes, breathing issues or other underlying condition flares.

  • Withdrawal signs
    Fatigue, dizziness, nausea, muscle or joint aches.
    If these occur, pause the taper or increase by the last dose reduction and discuss with your doctor.

  • Vital signs
    Periodic blood pressure checks—especially if you feel lightheaded when standing.

  • Lab tests
    Your doctor may check cortisol levels or inflammatory markers to guide the taper.


Lifestyle Support During Taper

Supporting your body can ease the transition off prednisone.

  • Nutrition

    • Eat a balanced diet rich in fruits, vegetables, lean protein and whole grains.
    • Aim for sufficient calcium (1,000–1,200 mg/day) and vitamin D (600–800 IU/day) to protect bone health.
  • Exercise

    • Low-impact activities (walking, swimming, yoga) improve mood, bone strength and help maintain muscle mass.
  • Stress management

    • Practice mindfulness, deep-breathing exercises or gentle stretching to help your body adapt.
  • Sleep and rest

    • Aim for 7–9 hours of quality sleep nightly.
    • Short daytime breaks can reduce fatigue during the taper.

Can I Drink Alcohol While Taking Prednisone 20 mg?

Many people wonder about alcohol use while on prednisone, especially at a moderate dose like 20 mg daily:

  • Moderation is key
    Occasional, light drinking (1 drink for women, up to 2 for men) is unlikely to cause major problems for most healthy adults.

  • Potential risks

    • Prednisone increases stomach acid and can weaken your stomach lining. Alcohol adds further irritation, raising risk of gastritis or ulcers.
    • Both alcohol and prednisone can affect blood sugar levels. If you have diabetes, monitor blood glucose more closely.
    • Alcohol may worsen insomnia, a common side effect of steroids.
  • When to be extra cautious

    • History of peptic ulcer disease, gastritis or gastrointestinal bleeding.
    • Liver disease or heavy alcohol use.
    • Taking other medications (NSAIDs, blood thinners) that increase bleeding risk.
  • Practical tips

    • Avoid drinking on an empty stomach; eat a small snack first.
    • Stay hydrated with water between alcoholic drinks.
    • Discuss your alcohol intake honestly with your doctor—they can help you weigh risks and benefits.

Monitoring Your Symptoms

As you taper, stay alert to changes in how you feel. If anything feels off:

  • Use a free, online symptom check, using the doctor approved Ubie Symptom Checker to track early warning signs and get guidance at ubiehealth.com.

  • Keep a daily journal of:

    • Prednisone dose and date
    • Any return of symptoms or new side effects
    • Mood, energy levels, pain, appetite
  • Share your journal at every follow-up appointment so your provider can adjust your taper if needed.


When to Contact Your Doctor Immediately

While many mild withdrawal symptoms can be managed with a slower taper, seek immediate medical attention if you experience:

  • Severe dizziness or fainting spells
  • Uncontrolled vomiting or diarrhea
  • Signs of adrenal crisis: confusion, severe weakness, very low blood pressure
  • High fever or signs of serious infection

These could indicate serious complications or life-threatening issues.


Key Takeaways

  • Never stop prednisone “cold turkey” after weeks-to-months of use.
  • Taper schedules vary; higher doses and longer use demand slower reductions.
  • Watch for withdrawal symptoms and disease flare-ups—pause or reverse taper if needed.
  • Support your taper with good nutrition, exercise, stress management and sleep.
  • Moderate alcohol intake (for example, 1 standard drink) is usually safe with prednisone 20 mg, but limits and timing matter. Always discuss alcohol use with your doctor.
  • Track your symptoms with tools like the free, online symptom check, using the doctor approved Ubie Symptom Checker at ubiehealth.com.
  • For any life-threatening or serious changes, speak to a doctor right away.

Always remember that your prescribing physician knows your medical history best. Speak to a doctor about any concerns—especially if you suspect serious side effects or complications. Your health and safety come first.

(References)

  • * Prussick R, Shear NH. Dapsone hypersensitivity syndrome. J Am Acad Dermatol. 1996 Aug;35(2 Pt 2):346-9. doi: 10.1016/s0190-9622(96)90667-2. PMID: 8698924.

  • * Stone JH, Tuckwell K, Dimonaco S, Klearman M, Aringer M, Blockmans D, Brouwer E, Cid MC, Dasgupta B, Rech J, Salvarani C, Schett G, Schulze-Koops H, Spiera R, Unizony SH, Collinson N. Trial of Tocilizumab in Giant-Cell Arteritis. N Engl J Med. 2017 Jul 27;377(4):317-328. doi: 10.1056/NEJMoa1613849. PMID: 28745999.

  • * Jayne DRW, Merkel PA, Schall TJ, Bekker P, ADVOCATE Study Group. Avacopan for the Treatment of ANCA-Associated Vasculitis. N Engl J Med. 2021 Feb 18;384(7):599-609. doi: 10.1056/NEJMoa2023386. PMID: 33596356.

  • * Spiera RF, Unizony S, Warrington KJ, Sloane J, Giannelou A, Nivens MC, Akinlade B, Wong W, Bhore R, Lin Y, Buttgereit F, Devauchelle-Pensec V, Rubbert-Roth A, Yancopoulos GD, Marrache F, Patel N, Dasgupta B, SAPHYR Investigators. Sarilumab for Relapse of Polymyalgia Rheumatica during Glucocorticoid Taper. N Engl J Med. 2023 Oct 5;389(14):1263-1272. doi: 10.1056/NEJMoa2303452. PMID: 37792612.

  • * De Miguel E, Karalilova R, Macchioni P, Ponte C, Conticini E, Cowley S, Tomelleri A, Monti S, Monjo I, Batalov Z, Klinowski G, Falsetti P, Kane DJ, Campochiaro C, Hočevar A. Subclinical giant cell arteritis increases the risk of relapse in polymyalgia rheumatica. Ann Rheum Dis. 2024 Feb 15;83(3):335-341. doi: 10.1136/ard-2023-224768. Epub 2024 Feb 15. PMID: 37932008.

  • * Gawrieh S, Dasarathy S, Tu W, Kamath PS, Chalasani NP, McClain CJ, Bataller R, Szabo G, Tang Q, Radaeva S, Barton B, Nagy LE, Shah VH, Sanyal AJ, Mitchell MC, AlcHepNet Investigators. Randomized trial of anakinra plus zinc vs. prednisone for severe alcohol-associated hepatitis. J Hepatol. 2024 May;80(5):684-693. doi: 10.1016/j.jhep.2024.01.031. Epub 2024 Feb 10. PMID: 38342441; PMCID: PMC11214682.

  • * Cai L, Li G, Abdulaziz AT, Gong X, Liu X, Kong X, Guo K, Li A, Li J, Zhou D, Hong Z. Efficacy and safety of different oral prednisone tapering courses in adult anti-NMDAR encephalitis: A multicenter prospective cohort study. Epilepsia. 2024 Nov;65(11):3199-3215. doi: 10.1111/epi.18107. Epub 2024 Sep 26. PMID: 39324872.

  • * Wang R, Lin Q, Sheng L, Zhang Y, Wen H, Li Y, Shi M, Xiao X, Yan L, Guo C, Miao Q, Hua J, Huang Z, Li H, Gershwin ME, Wang Q, Ma X, Lian M. Optimizing the tapering scheme of corticosteroid treatment for acute onset of autoimmune hepatitis. J Autoimmun. 2025 Mar;152:103387. doi: 10.1016/j.jaut.2025.103387. Epub 2025 Feb 26. PMID: 40015068.

  • * Adalimumab versus Conventional Immunosuppression for Uveitis Trial Research Group, Jabs DA, Sugar EA, Burke AE, Altaweel M, Thorne JE, Baksh S, Lim L, Thomas A, Yeh S, Holbrook JT. Adalimumab versus Conventional Immunosuppression for Uveitis (ADVISE) Trial. Ophthalmology. 2026 Mar;133(3):310-325. doi: 10.1016/j.ophtha.2025.10.004. Epub 2025 Oct 11. PMID: 41077357; PMCID: PMC13001625.

  • * Stone JH, Buttgereit F, Saraux A, Schmidt WA, Dejaco C, Spiera R, Dasgupta B, Drescher E, Jordan A, Novosad L, Nakagomi D, Koyama Y, Duran-Barragan S, Tracey G, Ruyssen-Witrand A, Rubbert Roth A, Fang J, Ng J, Hiremath R, Raffner R, Martin R, Napoletano S, Huang S, Storim J, Patekar M, REPLENISH Investigators. Phase 3 Trial of Secukinumab in Polymyalgia Rheumatica. N Engl J Med. 2026 Aug 13;395(7):637-647. doi: 10.1056/NEJMoa2602567. Epub 2026 Jun 3. PMID: 42234540.

Thinking about asking ChatGPT?Ask me instead

Tell your friends about us.

We would love to help them too.

smily Shiba-inu looking

For First Time Users

What is Ubie’s Doctor’s Note?

We provide a database of explanations from real doctors on a range of medical topics. Get started by exploring our library of questions and topics you want to learn more about.

Was this page helpful?

Purpose and positioning of servicesUbie Doctor's Note is a service for informational purposes. The provision of information by physicians, medical professionals, etc. is not a medical treatment. If medical treatment is required, please consult your doctor or medical institution. We strive to provide reliable and accurate information, but we do not guarantee the completeness of the content. If you find any errors in the information, please contact us.